Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Is the Mexican abortion pill safe?

Jennifer Gunter, MD
Meds
August 6, 2013
Share
Tweet
Share

With Governor Rick Perry signing the restrictive Texas abortion bill into law many news organizations have shed light on traveling to Mexico for abortion and there has been much talk about the “Mexican abortion pill.”

The medication that people typically call the Mexican abortion pill is misoprostol, marketed under the trade name Cytotec. It is a prostaglandin analogue and is used for prevention of stomach ulcers. It also has many uses in OB/GYN such as inducing labor, preparing the cervix for a therapeutic abortion, treating a missed abortion (a miscarriage where the pregnancy ends, but the uterus fails to empty), and as part of the two drug regimen for medical termination of pregnancy (medical abortion).

With medical abortion the most effective regimen is 200 mg of oral mifepristone (RU-486) followed by 800 mcg of misoprostol given vaginally 6-24 hours later. This regimen is 95-99% effective at terminating a pregnancy up to 63 days gestational age (9 weeks) with an extremely low rate of serious complications.

Studies have also looked at misoprostol alone and it is fairly effective. When 800 mcg of misoprostol is moistened with water and used vaginal and repeated every 24 hours (up to 3 doses) the success rate is 88% for terminating pregnancies up to 56 days gestation (8 weeks). You might say, “Well, 88% isn’t bad!” but that is significantly less effective than the mifepristone-misoprostol combination.

How safe is a misoprostol only regimen? It’s not inherently unsafe or dangerous if supervised, but therein lies the issue. If a woman is driving across the border to get the tablets it isn’t a stretch to say that she is unsupervised and hasn’t been adequately screened.

If a woman is further along than she thinks and uses the misoprostol only regimen she could have catastrophically heavy bleeding and not know when to call for help. In addition, about 1% of women who use this method appropriately will bleed enough they need expert intervention. A woman who got her medications from Mexico may feel too much stigma or may be medically disadvantaged enough to get appropriate help.

Inadequate screening may also lead a woman with an undiagnosed ectopic pregnancy to use misoprostol with devastating complications. Other issues surround the failure rate. If the pregnancy fails to abort and a surgical termination isn’t possible (this will happen for at least 12% of women, but likely more because many women who resort to getting misoprostol in Mexico will likely be further along than 56 days), the pregnancies that continue may be at increased risk of birth defects.

According to the American Congress of Obstetricians and Gynecologists (ACOG) mifepristone/misoprostol 200 mg/800mcg is the preferred regimen.

Unless the law is overturned women in Texas needing abortion are likely to get a less effective regimen with no supervision and somehow this will make abortion “safer” for women.

Jennifer Gunter is an obstetrician-gynecologist and author of The Preemie Primer. She blogs at her self-titled site, Dr. Jen Gunter.

Prev

Technologists versus doctors: Who wins?

August 5, 2013 Kevin 8
…
Next

Limiting your choice of doctors: Is Obamacare to blame?

August 6, 2013 Kevin 10
…

Tagged as: Medications, OB/GYN

Post navigation

< Previous Post
Technologists versus doctors: Who wins?
Next Post >
Limiting your choice of doctors: Is Obamacare to blame?

ADVERTISEMENT

More by Jennifer Gunter, MD

  • The Ellen Show broadcasts potentially harmful information about ovarian cancer screening

    Jennifer Gunter, MD
  • Dear science: an appreciation

    Jennifer Gunter, MD
  • Are there too many female OB/GYNs?

    Jennifer Gunter, MD

More in Meds

  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • How undermining physicians harms society

      Olumuyiwa Bamgbade, MD | Physician
    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • What psychiatry can teach all doctors

      Farid Sabet-Sharghi, MD | Physician
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
  • Recent Posts

    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • The problem with laboratory reference ranges

      Larry Kaskel, MD | Conditions
    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions
    • The crisis in modern autism diagnosis

      Ronald L. Lindsay, MD | Conditions
    • A poem about being seen by your doctor

      Michele Luckenbaugh | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 13 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • How undermining physicians harms society

      Olumuyiwa Bamgbade, MD | Physician
    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • What psychiatry can teach all doctors

      Farid Sabet-Sharghi, MD | Physician
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
  • Recent Posts

    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • The problem with laboratory reference ranges

      Larry Kaskel, MD | Conditions
    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions
    • The crisis in modern autism diagnosis

      Ronald L. Lindsay, MD | Conditions
    • A poem about being seen by your doctor

      Michele Luckenbaugh | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Is the Mexican abortion pill safe?
13 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...